non-opioid painkiller

News

Novo Holdings leads $100m round for novel painkiller biotech

SiteOne Therapeutics has completed a $100 million third-round financing that will support clinical trials of its non-opioid painkiller.

R&D

Non-opioid painkillers: Another tool to fight the opioid epi...

The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control.

News

Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller

Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therap

Novo Holdings leads $100m round for novel painkiller biotech

Non-opioid painkillers: Another tool to fight the opioid epi...

Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks